Mink Historical Balance Sheet
| INKT Stock | USD 0.97 0.01 1.04% |
Trend analysis of Mink Therapeutics balance sheet accounts such as Other Current Liabilities of 8.6 M or Total Current Liabilities of 13.7 M provides information on Mink Therapeutics' total assets, liabilities, and equity, which is the actual value of Mink Therapeutics to its prevalent stockholders. By breaking down trends over time using Mink Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Mink Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mink Therapeutics is a good buy for the upcoming year.
Mink Therapeutics Inventory |
|
Mink |
About Mink Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Mink Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Mink Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Mink Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Mink currently owns. An asset can also be divided into two categories, current and non-current.
Mink Therapeutics Balance Sheet Chart
Mink Therapeutics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Mink Therapeutics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Mink Therapeutics' Other Current Liabilities is comparatively stable compared to the past year. Total Current Liabilities is likely to gain to about 13.7 M in 2024, whereas Net Tangible Assets are likely to drop (484.6 K) in 2024. Add Fundamental
Total Assets
Total assets refers to the total amount of Mink Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Mink Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Mink Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Mink Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Mink Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Mink Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Mink Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.At this time, Mink Therapeutics' Other Current Liabilities is comparatively stable compared to the past year. Total Current Liabilities is likely to gain to about 13.7 M in 2024, whereas Net Tangible Assets are likely to drop (484.6 K) in 2024.
| 2023 | 2024 (projected) | Short and Long Term Debt Total | 50.4M | 38.8M | Total Assets | 4.6M | 4.3M |
Mink Therapeutics balance sheet Correlations
Click cells to compare fundamentals
Mink Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Mink Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mink Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Mink Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mink Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mink Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mink Therapeutics to buy it.
The correlation of Mink Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mink Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mink Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mink Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Mink Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Mink Stock analysis
When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Mink Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mink Therapeutics. If investors know Mink will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mink Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Return On Assets (1.10) | Return On Equity (12.39) |
The market value of Mink Therapeutics is measured differently than its book value, which is the value of Mink that is recorded on the company's balance sheet. Investors also form their own opinion of Mink Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Mink Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mink Therapeutics' market value can be influenced by many factors that don't directly affect Mink Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mink Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mink Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mink Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.